TRPV4 Protects the Lung from Bacterial Pneumonia via MAPK Molecular Pathway Switching.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
01 03 2020
Historique:
received: 23 08 2019
accepted: 22 12 2019
pubmed: 24 1 2020
medline: 9 9 2020
entrez: 24 1 2020
Statut: ppublish

Résumé

Mechanical cell-matrix interactions can drive the innate immune responses to infection; however, the molecular underpinnings of these responses remain elusive. This study was undertaken to understand the molecular mechanism by which the mechanosensitive cation channel, transient receptor potential vanilloid 4 (TRPV4), alters the in vivo response to lung infection. For the first time, to our knowledge, we show that TRPV4 protects the lung from injury upon intratracheal

Identifiants

pubmed: 31969384
pii: jimmunol.1901033
doi: 10.4049/jimmunol.1901033
pmc: PMC7033031
mid: NIHMS1547579
doi:

Substances chimiques

Lipopolysaccharides 0
TRPV Cation Channels 0
TRPV4 protein, human 0
Trpv4 protein, mouse 0
Mitogen-Activated Protein Kinase Kinases EC 2.7.12.2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1310-1321

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002548
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000439
Pays : United States
Organisme : NHLBI NIH HHS
ID : K08 HL132079
Pays : United States
Organisme : NIH HHS
ID : S10 OD019972
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL133721
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL119792
Pays : United States
Organisme : NHLBI NIH HHS
ID : K08 HL133380
Pays : United States

Informations de copyright

Copyright © 2020 by The American Association of Immunologists, Inc.

Références

Mol Biol Cell. 2002 Jun;13(6):1940-52
pubmed: 12058061
Physiol Rev. 2016 Jul;96(3):911-73
pubmed: 27252279
Pediatr Res. 1987 Dec;22(6):698-702
pubmed: 3431954
Am J Pathol. 2013 May;182(5):1572-84
pubmed: 23499373
Am J Physiol Lung Cell Mol Physiol. 2014 Jul 15;307(2):L158-72
pubmed: 24838754
Nat Immunol. 2008 Sep;9(9):1019-27
pubmed: 18677317
J Leukoc Biol. 2018 Jan;103(1):23-33
pubmed: 29345058
Nature. 2014 Oct 23;514(7523):450-4
pubmed: 25274301
Nat Commun. 2017 Oct 20;8(1):1059
pubmed: 29057902
Science. 1994 Aug 5;265(5173):808-11
pubmed: 7914033
Cytokine Growth Factor Rev. 2003 Dec;14(6):523-35
pubmed: 14563354
Oncotarget. 2016 Jun 21;7(25):37622-37635
pubmed: 27191895
Am J Respir Cell Mol Biol. 2015 Feb;52(2):152-61
pubmed: 24992633
JAMA. 2016 Feb 23;315(8):788-800
pubmed: 26903337
J Immunol. 2015 Feb 1;194(3):1239-51
pubmed: 25520401
N Engl J Med. 2000 May 4;342(18):1334-49
pubmed: 10793167
FASEB J. 2019 Jan;33(1):195-203
pubmed: 29957061
Nat Rev Dis Primers. 2019 Mar 14;5(1):19
pubmed: 30872579
Front Mol Biosci. 2016 Jun 28;3:28
pubmed: 27446931
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17253-8
pubmed: 24101477
Nature. 2014 Jan 2;505(7481):56-61
pubmed: 24270805
J Clin Invest. 2014 Dec;124(12):5225-38
pubmed: 25365224
Am J Physiol Lung Cell Mol Physiol. 2007 Oct;293(4):L923-32
pubmed: 17660328
J Immunol. 2006 Dec 1;177(11):7497-504
pubmed: 17114416
Cell Death Differ. 2009 Oct;16(10):1323-31
pubmed: 19461656
J Biol Chem. 2010 Dec 31;285(53):41280-9
pubmed: 21044959
Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):602-11
pubmed: 8810593
Int J Cardiol. 2016 Jan 15;203:145-55
pubmed: 26512830
Front Oncol. 2018 May 04;8:145
pubmed: 29780748
Cell. 2013 Jul 3;154(1):197-212
pubmed: 23827683
J Cell Biol. 1991 Oct;115(1):59-66
pubmed: 1918139
Am J Physiol Cell Physiol. 2000 Oct;279(4):C1155-67
pubmed: 11003596
J Immunol. 2016 Jan 1;196(1):428-36
pubmed: 26597012
Exp Ther Med. 2014 Jul;8(1):153-158
pubmed: 24944614
Am J Physiol Cell Physiol. 2017 May 1;312(5):C562-C572
pubmed: 28249987
Cell Death Dis. 2015 Jun 04;6:e1775
pubmed: 26043075
Cell Rep. 2018 Jul 10;24(2):366-378
pubmed: 29996098
J Immunol. 2008 Apr 1;180(7):5075-82
pubmed: 18354233
Front Immunol. 2017 May 04;8:503
pubmed: 28523001
Eur J Biochem. 1983 Apr 5;131(3):539-43
pubmed: 6301813
Am J Physiol Cell Physiol. 2003 Jul;285(1):C96-101
pubmed: 12777254
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1896-903
pubmed: 11734443
J Immunol. 2005 Nov 1;175(9):6058-64
pubmed: 16237101
Curr Opin Immunol. 2012 Aug;24(4):424-30
pubmed: 22841348
Biochem J. 2010 Aug 1;429(3):403-17
pubmed: 20626350
Cell Motil Cytoskeleton. 2006 Jun;63(6):321-40
pubmed: 16634082
Am J Physiol Lung Cell Mol Physiol. 2010 Sep;299(3):L353-62
pubmed: 20562229
Am J Respir Cell Mol Biol. 2018 May;58(5):614-624
pubmed: 29115856
Matrix Biol. 2018 Nov;73:122-134
pubmed: 29649546
Cell Res. 2002 Mar;12(1):9-18
pubmed: 11942415
Lab Anim. 2002 Jul;36(3):291-312
pubmed: 12144741
Am J Respir Cell Mol Biol. 2013 Oct;49(4):503-10
pubmed: 23672262
PLoS One. 2010 Jul 19;5(7):e11654
pubmed: 20657843
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):396-401
pubmed: 14691263
Eur Respir J. 2014 Jan;43(1):276-85
pubmed: 23520315
Prog Biophys Mol Biol. 2010 Sep;103(1):2-17
pubmed: 19835908
Am J Respir Cell Mol Biol. 2018 Jan;58(1):66-78
pubmed: 28850249
J Exp Med. 2006 Jan 23;203(1):15-20
pubmed: 16380512
J Immunol. 2015 Feb 1;194(3):855-60
pubmed: 25596299
J Biol Chem. 2002 Oct 4;277(40):37401-5
pubmed: 12171911
J Biol Chem. 2003 Jul 18;278(29):27129-37
pubmed: 12738791
Biochem Soc Trans. 2006 Dec;34(Pt 6):1018-23
pubmed: 17073741
Cell Rep. 2019 Apr 16;27(3):793-805.e4
pubmed: 30995477
Clin Infect Dis. 2006 Sep 15;43(6):748-56
pubmed: 16912951
Mediators Inflamm. 2014;2014:352371
pubmed: 24771982
Am J Respir Crit Care Med. 1994 Jul;150(1):113-22
pubmed: 8025736
J Am Heart Assoc. 2013 Apr 25;2(3):e000080
pubmed: 23619744
Circ Res. 2014 Feb 14;114(4):616-25
pubmed: 24347665
Biochim Biophys Acta. 2011 Jul;1808(7):1913-20
pubmed: 21510917
J Cell Sci. 2001 Mar;114(Pt 6):1221-7
pubmed: 11228165
Cell. 2002 Mar 8;108(5):595-8
pubmed: 11893331

Auteurs

Rachel G Scheraga (RG)

Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195; olmanm@ccf.org scherar@ccf.org.
Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; and.

Susamma Abraham (S)

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; and.

Lisa M Grove (LM)

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; and.

Brian D Southern (BD)

Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195.
Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; and.

James F Crish (JF)

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; and.

Apostolos Perelas (A)

Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195.

Christine McDonald (C)

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; and.

Kewal Asosingh (K)

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; and.

Jeffrey D Hasday (JD)

Department of Pulmonary and Critical Care, University of Maryland, Baltimore, MD 21201.

Mitchell A Olman (MA)

Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195; olmanm@ccf.org scherar@ccf.org.
Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH